Loading...

The current price of PRFX is 0.8875 USD — it has decreased -8.55 % in the last trading day.
PAINREFORM LTD is a Israel-based pharmaceutical Company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.
Wall Street analysts forecast PRFX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PRFX is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
PainReform Ltd revenue for the last quarter amounts to -7.35M USD, increased 226.15 % YoY.
PainReform Ltd. EPS for the last quarter amounts to -4954000.00 USD, increased 147.33 % YoY.
PainReform Ltd (PRFX) has 2 emplpoyees as of December 15 2025.
Today PRFX has the market capitalization of 3.80M USD.